Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication [Phase 2]

View source ↗

Summary

Phase 2 study evaluating standardized natural psilocybin-assisted psychotherapy to help taper opioid use; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of British Columbia | Conditions: Opioid Dependence, Chronic Pain | Phase 2 | Status: RECRUITING